eleclazine: Clinical Trials

3 trials of eleclazine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 withdrawn. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Terminated 1, Withdrawn 1
Phase 31Terminated 1

Follow eleclazine: new trials by email Literature Review of eleclazine trials Research Report on eleclazine

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease
GS-6615, Placebo - Ischemic Heart Disease
Phase 2WithdrawnGilead Sciences2015-05-012015-06-08
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Eleclazine, Placebo - Hypertrophic Cardiomyopathy
Phase 2 / Phase 3TerminatedGilead Sciences1722015-02-052018-09-24
Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator
Eleclazine, Placebo to match eleclazine - Ventricular Arrhythmia
Phase 2CompletedGilead Sciences3132014-09-012019-04-09

Conditions studied

Angina Pectoris (2)  ·  Angina, Stable (1)  ·  Cardiomyopathies (1)  ·  Cardiomyopathy, Hypertrophic (1)  ·  Cardiomyopathy, Hypertrophic, Familial (1)  ·  Coronary Artery Disease (1)  ·  Coronary Disease (1)  ·  Dyspnea (1)  ·  Heart Failure (1)  ·  Hypertrophy (1)  ·  Myocardial Ischemia (1)  ·  Shock (1)  ·  Tachycardia, Ventricular (1)  ·  Ventricular Fibrillation (1)

Sponsors

Gilead Sciences (3)

Countries

Germany (2)  ·  Israel (2)  ·  Netherlands (2)  ·  United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Hungary (1)  ·  Italy (1)  ·  Poland (1)  ·  United Kingdom (1)

Top investigators

Patrick Yue, MD (1)

NIH funding

2014 (1)